,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Femur fracture,6,17191202
1,22.1,Pain,6,17191202
2,22.1,Lower limb fracture,6,17191202
3,22.1,Fall,6,17191202
4,22.1,Neoplasm progression,6,17191202
5,22.1,Somnolence,6,17191202
0,22.1,Toxicity to various agents,5,17191209
1,22.1,Death,5,17191209
0,22.1,Meningioma,3,17191261
0,22.1,Pancreatitis,1,17191314
1,22.1,Flatulence,1,17191314
2,22.1,Lipase abnormal,1,17191314
0,22.1,Ulcerative keratitis,3,17191334
0,22.1,Syncope,,17191340
1,22.1,Fall,,17191340
0,22.1,Death,5,17191372
0,22.1,Rash,2,17191393
1,22.1,Platelet count decreased,6,17191393
2,22.1,Pancytopenia,6,17191393
3,22.1,Blood pressure increased,2,17191393
4,22.1,Diarrhoea,2,17191393
0,22.1,Disease recurrence,6,17191394
1,22.1,Bone marrow toxicity,6,17191394
2,22.1,Anaemia,6,17191394
3,22.1,Therapy partial responder,6,17191394
4,22.1,Toxicity to various agents,6,17191394
0,22.1,Influenza like illness,1,17191399
0,22.1,Metastases to central nervous system,3,17191408
1,22.1,Malignant neoplasm progression,3,17191408
2,22.1,Full blood count decreased,3,17191408
3,22.1,Asthenia,3,17191408
4,22.1,Breast cancer,3,17191408
5,22.1,Fatigue,3,17191408
0,22.1,Alopecia,3,17191452
0,22.1,Product prescribing issue,6,17191456
1,22.1,Malaise,6,17191456
0,22.1,Fatigue,6,17191464
1,22.1,Diarrhoea,6,17191464
2,22.1,Nausea,6,17191464
0,22.1,Stomatitis,,17191521
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,,17191521
0,22.1,Death,,17191524
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,1,17191529
1,22.1,Arthritis,1,17191529
0,22.1,Neoplasm progression,3,17191571
0,22.1,Product use in unapproved indication,6,17191581
1,22.1,Off label use,6,17191581
2,22.1,Neoplasm progression,3,17191581
3,22.1,Product dispensing error,6,17191581
0,22.1,Hypoaesthesia,3,17191585
1,22.1,Neuropathy peripheral,6,17191585
2,22.1,Skin exfoliation,3,17191585
0,22.1,Neutropenia,6,17191592
0,22.1,Leukopenia,6,17191598
0,22.1,Abdominal pain upper,6,17191608
1,22.1,Swelling,6,17191608
2,22.1,Nasopharyngitis,6,17191608
3,22.1,Fatigue,6,17191608
4,22.1,Dry mouth,3,17191608
5,22.1,Muscle spasms,6,17191608
6,22.1,Skin exfoliation,6,17191608
7,22.1,Cerebral haemorrhage,6,17191608
8,22.1,Diarrhoea,3,17191608
9,22.1,Rash,6,17191608
10,22.1,Headache,6,17191608
11,22.1,Dyspnoea,6,17191608
12,22.1,Hypertension,6,17191608
13,22.1,Flatulence,6,17191608
14,22.1,Tongue discomfort,3,17191608
15,22.1,Raynaud^s phenomenon,3,17191608
16,22.1,Drug ineffective,6,17191608
17,22.1,Bacterial infection,3,17191608
18,22.1,Alopecia,6,17191608
19,22.1,Tumour marker increased,6,17191608
0,22.1,Fall,6,17191622
0,22.1,Interstitial lung disease,2,17191637
0,22.1,Hyperglycaemia,1,17191638
1,22.1,Respiratory failure,5,17191638
2,22.1,Hepatic encephalopathy,3,17191638
3,22.1,Dehydration,1,17191638
0,22.1,Gastritis,3,17191645
1,22.1,Hepatic function abnormal,3,17191645
2,22.1,Metastases to bone,3,17191645
3,22.1,Nausea,3,17191645
4,22.1,Peripheral swelling,3,17191645
5,22.1,Vasodilatation,3,17191645
6,22.1,Anxiety,3,17191645
7,22.1,Arthralgia,3,17191645
8,22.1,Blood pressure decreased,3,17191645
9,22.1,Decreased appetite,3,17191645
10,22.1,Drug ineffective,3,17191645
11,22.1,Impaired healing,3,17191645
12,22.1,Paraesthesia,3,17191645
13,22.1,Road traffic accident,3,17191645
14,22.1,Skin sensitisation,3,17191645
15,22.1,Abdominal discomfort,3,17191645
16,22.1,Abdominal pain upper,3,17191645
17,22.1,Blood cholesterol increased,3,17191645
18,22.1,Infusion site pain,3,17191645
19,22.1,Injection site swelling,3,17191645
20,22.1,Malaise,3,17191645
21,22.1,Vein disorder,3,17191645
22,22.1,Blood potassium increased,3,17191645
23,22.1,Body temperature decreased,3,17191645
24,22.1,Dizziness,3,17191645
25,22.1,Headache,3,17191645
26,22.1,Influenza like illness,3,17191645
27,22.1,Infusion site coldness,3,17191645
28,22.1,Infusion site induration,3,17191645
29,22.1,Peripheral coldness,3,17191645
30,22.1,Rash,3,17191645
31,22.1,Spinal pain,3,17191645
32,22.1,Asthenia,3,17191645
33,22.1,Blood creatinine decreased,3,17191645
34,22.1,Chills,3,17191645
35,22.1,Flushing,3,17191645
36,22.1,Immunodeficiency,3,17191645
37,22.1,Injection site mass,3,17191645
38,22.1,Neutrophil count decreased,3,17191645
39,22.1,Platelet count decreased,3,17191645
40,22.1,Pyrexia,3,17191645
41,22.1,Retinal detachment,3,17191645
42,22.1,Toothache,3,17191645
43,22.1,White blood cell count decreased,3,17191645
44,22.1,Abdominal distension,3,17191645
45,22.1,Drug hypersensitivity,3,17191645
46,22.1,Fatigue,3,17191645
47,22.1,Hypoaesthesia,3,17191645
48,22.1,Incontinence,3,17191645
49,22.1,Injection site bruising,3,17191645
50,22.1,Mean cell haemoglobin decreased,3,17191645
51,22.1,Oedema peripheral,3,17191645
52,22.1,Tooth disorder,3,17191645
53,22.1,Bone pain,3,17191645
54,22.1,Feeling cold,3,17191645
55,22.1,Feeling hot,3,17191645
56,22.1,Gamma-glutamyltransferase decreased,3,17191645
57,22.1,Infusion site haemorrhage,3,17191645
58,22.1,Migraine,3,17191645
59,22.1,Pain,3,17191645
60,22.1,Pain in extremity,3,17191645
61,22.1,Poor venous access,3,17191645
62,22.1,Post-traumatic neck syndrome,3,17191645
63,22.1,Urticaria,3,17191645
64,22.1,Back pain,3,17191645
65,22.1,Chest pain,3,17191645
66,22.1,Contusion,3,17191645
67,22.1,Dehydration,3,17191645
68,22.1,Injection site erythema,3,17191645
69,22.1,Muscle spasms,3,17191645
70,22.1,Pain in jaw,3,17191645
0,22.1,Anxiety,1,17191655
1,22.1,Bronchospasm,1,17191655
2,22.1,Dyspnoea at rest,1,17191655
3,22.1,Erythema,1,17191655
0,22.1,Hepatic function abnormal,6,17191657
1,22.1,Diarrhoea,6,17191657
0,22.1,Acute kidney injury,1,17191672
0,22.1,Transient ischaemic attack,2,17191702
0,22.1,Oral mucosal blistering,6,17191722
1,22.1,Nodule,6,17191722
2,22.1,Pruritus,6,17191722
3,22.1,Haemorrhage,6,17191722
4,22.1,Dyspnoea,6,17191722
5,22.1,Neoplasm progression,6,17191722
6,22.1,Rectal haemorrhage,6,17191722
7,22.1,Skin infection,6,17191722
8,22.1,Blood urine present,6,17191722
9,22.1,Malaise,6,17191722
10,22.1,Blister infected,6,17191722
11,22.1,Genital discomfort,6,17191722
0,22.1,Death,5,17191751
1,22.1,Inappropriate schedule of product administration,6,17191751
2,22.1,Product use in unapproved indication,6,17191751
0,22.1,Blood count abnormal,6,17191793
0,22.1,Cerebral infarction,1,17191842
1,22.1,Haemorrhage,1,17191842
0,22.1,General physical health deterioration,6,17191898
0,22.1,Dyspnoea,5,17191901
1,22.1,Peripheral swelling,5,17191901
2,22.1,Decreased appetite,6,17191901
3,22.1,Anxiety,6,17191901
4,22.1,Malaise,6,17191901
5,22.1,White blood cell count decreased,6,17191901
6,22.1,Platelet count decreased,6,17191901
7,22.1,Stomatitis,6,17191901
0,22.1,Hyperthyroidism,3,17191925
0,22.1,Colon cancer metastatic,5,17191936
0,22.1,Foot fracture,3,17191940
1,22.1,Pain in extremity,2,17191940
0,22.1,Death,5,17191952
0,22.1,Pneumonitis,6,17191956
0,22.1,Death,5,17191990
0,22.1,Colon cancer,3,17192007
0,22.1,Diverticulitis,1,17192028
0,22.1,Weight decreased,6,17192035
1,22.1,Fall,6,17192035
0,22.1,Oesophageal stenosis,1,17192045
0,22.1,Anaphylactic reaction,1,17192051
1,22.1,Rash macular,1,17192051
2,22.1,Pyrexia,1,17192051
0,22.1,Chest pain,2,17192058
1,22.1,Haematemesis,1,17192058
2,22.1,Ulcer,2,17192058
3,22.1,Stoma site haemorrhage,1,17192058
0,22.1,Dyspnoea,6,17192062
1,22.1,Pulmonary embolism,6,17192062
2,22.1,Hepatic enzyme increased,6,17192062
3,22.1,Fluid retention,6,17192062
4,22.1,Cardiac failure congestive,6,17192062
5,22.1,Fall,6,17192062
6,22.1,Bladder disorder,6,17192062
7,22.1,Cognitive disorder,6,17192062
0,22.1,Colitis,3,17192081
0,22.1,Febrile neutropenia,1,17192093
0,22.1,Bone marrow failure,6,17192159
1,22.1,Thrombocytopenia,2,17192159
2,22.1,Thrombosis,6,17192159
3,22.1,Fatigue,2,17192159
4,22.1,Oral pain,2,17192159
5,22.1,Nausea,2,17192159
6,22.1,Platelet count decreased,2,17192159
7,22.1,Pyrexia,6,17192159
8,22.1,Chronic kidney disease,6,17192159
9,22.1,Condition aggravated,6,17192159
10,22.1,Chills,6,17192159
11,22.1,Leukopenia,2,17192159
12,22.1,Mouth ulceration,6,17192159
13,22.1,Oropharyngeal pain,2,17192159
14,22.1,White blood cell count decreased,2,17192159
15,22.1,Anaemia,6,17192159
16,22.1,Rhinorrhoea,6,17192159
17,22.1,Skin ulcer,6,17192159
0,22.1,Fatigue,1,17192183
1,22.1,Erythema multiforme,1,17192183
2,22.1,Periodontal disease,1,17192183
3,22.1,Peripheral sensory neuropathy,3,17192183
4,22.1,Ototoxicity,3,17192183
5,22.1,Hypertension,3,17192183
0,22.1,Erysipelas,1,17192184
0,22.1,Hepatic enzyme increased,6,17192185
1,22.1,Off label use,6,17192185
0,22.1,Neutropenia,1,17192186
1,22.1,Abdominal pain upper,1,17192186
0,22.1,Vertigo,1,17192190
1,22.1,Nausea,1,17192190
0,22.1,Acute coronary syndrome,1,17192195
0,22.1,Atrial fibrillation,1,17192201
0,22.1,Second primary malignancy,6,17192209
1,22.1,Uterine cancer,6,17192209
0,22.1,Second primary malignancy,6,17192213
1,22.1,Cholangiocarcinoma,6,17192213
0,22.1,Second primary malignancy,6,17192214
1,22.1,Adenocarcinoma pancreas,6,17192214
0,22.1,Death,5,17192229
0,22.1,Cystitis,6,17192230
1,22.1,Thermal burn,3,17192230
2,22.1,Accident,6,17192230
3,22.1,Urine odour abnormal,6,17192230
4,22.1,Tibia fracture,6,17192230
5,22.1,Alopecia,6,17192230
6,22.1,Erythema,3,17192230
7,22.1,Gingival swelling,1,17192230
8,22.1,Urinary retention,6,17192230
9,22.1,Vulvovaginal discomfort,6,17192230
0,22.1,Prostate cancer,6,17192288
1,22.1,Cardio-respiratory arrest,5,17192288
0,22.1,Malignant neoplasm progression,5,17192358
1,22.1,Breast cancer metastatic,5,17192358
0,22.1,Osteoporosis,5,17192434
1,22.1,Movement disorder,5,17192434
2,22.1,Death,5,17192434
0,22.1,Disseminated intravascular coagulation,,17192458
0,22.1,Haematochezia,6,17192480
1,22.1,Product use in unapproved indication,6,17192480
0,22.1,Death,5,17192484
1,22.1,Malignant neoplasm progression,6,17192484
0,22.1,Drug ineffective,6,17192493
1,22.1,Headache,6,17192493
2,22.1,Vomiting,6,17192493
3,22.1,Metastases to central nervous system,5,17192493
0,22.1,Radiation pneumonitis,6,17192500
0,22.1,C-reactive protein increased,,17192504
0,22.1,Injection site inflammation,6,17192536
1,22.1,Injection site erythema,2,17192536
2,22.1,Injection site ulcer,2,17192536
3,22.1,Injection site discharge,6,17192536
4,22.1,Injection site induration,3,17192536
5,22.1,Injection site necrosis,6,17192536
6,22.1,Skin adhesion,6,17192536
7,22.1,Injection site abscess,2,17192536
8,22.1,Injection site reaction,2,17192536
9,22.1,Scar,6,17192536
10,22.1,Injection site infection,2,17192536
11,22.1,Injection site plaque,6,17192536
0,22.1,Death,5,17192577
0,22.1,Cardio-respiratory arrest,5,17192597
1,22.1,Diarrhoea,5,17192597
2,22.1,Bradycardia,5,17192597
3,22.1,Abdominal pain,5,17192597
4,22.1,Dehydration,5,17192597
5,22.1,Hypotension,5,17192597
0,22.1,Lip pruritus,1,17192606
1,22.1,Pruritus,1,17192606
2,22.1,Feeling hot,1,17192606
3,22.1,Swollen tongue,1,17192606
4,22.1,Swelling,1,17192606
5,22.1,Erythema,1,17192606
6,22.1,Urticaria,1,17192606
7,22.1,Oral pruritus,1,17192606
8,22.1,Swelling of eyelid,1,17192606
0,22.1,Neuropathy peripheral,6,17192627
1,22.1,Fatigue,3,17192627
2,22.1,Platelet count decreased,3,17192627
3,22.1,Melaena,1,17192627
0,22.1,Hypertension,6,17192631
1,22.1,Oxygen saturation decreased,6,17192631
2,22.1,Back pain,6,17192631
3,22.1,Dyspnoea,6,17192631
0,22.1,Malignant neoplasm progression,6,17192635
0,22.1,Influenza,6,17192638
0,22.1,Dyspnoea exertional,6,17192639
0,22.1,Dyspnoea,6,17192640
1,22.1,Off label use,6,17192640
2,22.1,Product use in unapproved indication,6,17192640
0,22.1,Neoplasm progression,6,17192641
0,22.1,Hair disorder,3,17192645
1,22.1,Madarosis,3,17192645
2,22.1,Hair texture abnormal,3,17192645
3,22.1,Hair colour changes,3,17192645
4,22.1,Alopecia,3,17192645
0,22.1,Oral pain,6,17192646
0,22.1,Neoplasm progression,1,17192648
0,22.1,Hypoacusis,3,17192649
0,22.1,Alopecia,2,17192660
0,22.1,Psychological trauma,6,17192672
1,22.1,Alopecia,3,17192672
0,22.1,Alopecia,3,17192675
1,22.1,Psychological trauma,6,17192675
0,22.1,Alopecia,2,17192676
1,22.1,Psychological trauma,6,17192676
0,22.1,Alopecia,2,17192680
1,22.1,Psychological trauma,6,17192680
0,22.1,Alopecia,2,17192683
1,22.1,Psychological trauma,6,17192683
0,22.1,Alopecia,2,17192684
1,22.1,Psychological trauma,6,17192684
0,22.1,Alopecia,2,17192687
1,22.1,Psychological trauma,6,17192687
0,22.1,Alopecia,2,17192688
0,22.1,Psychological trauma,6,17192690
1,22.1,Alopecia,2,17192690
0,22.1,Psychological trauma,6,17192691
1,22.1,Alopecia,2,17192691
0,22.1,Psychological trauma,6,17192693
1,22.1,Alopecia,2,17192693
0,22.1,Alopecia,2,17192694
0,22.1,Alopecia,2,17192698
0,22.1,Psychological trauma,6,17192700
1,22.1,Alopecia,2,17192700
0,22.1,Alopecia,2,17192701
0,22.1,Psychological trauma,6,17192705
1,22.1,Alopecia,2,17192705
0,22.1,Psychological trauma,6,17192706
1,22.1,Alopecia,2,17192706
0,22.1,Psychological trauma,6,17192708
1,22.1,Alopecia,2,17192708
0,22.1,Psychological trauma,6,17192709
1,22.1,Alopecia,2,17192709
0,22.1,Psychological trauma,6,17192714
1,22.1,Alopecia,3,17192714
0,22.1,Alopecia,2,17192716
1,22.1,Psychological trauma,6,17192716
0,22.1,Psychological trauma,6,17192717
1,22.1,Alopecia,2,17192717
0,22.1,Alopecia,2,17192727
0,22.1,Psychological trauma,6,17192733
1,22.1,Alopecia,2,17192733
0,22.1,Alopecia,2,17192734
1,22.1,Psychological trauma,6,17192734
0,22.1,Alopecia,3,17192800
1,22.1,Psychological trauma,6,17192800
2,22.1,Emotional distress,6,17192800
0,22.1,Alopecia,2,17192854
0,22.1,Cytopenia,1,17192899
1,22.1,Off label use,6,17192899
2,22.1,Malignant neoplasm progression,5,17192899
0,22.1,Hydrocephalus,3,17192902
1,22.1,Pneumonitis,1,17192902
2,22.1,Death,5,17192902
0,22.1,Back pain,6,17192906
1,22.1,Spinal fracture,6,17192906
0,22.1,Alopecia,2,17192981
1,22.1,Psychological trauma,6,17192981
0,22.1,Alopecia,2,17192986
0,22.1,Alopecia,2,17193011
1,22.1,Emotional distress,6,17193011
2,22.1,Pain,6,17193011
3,22.1,Anxiety,6,17193011
4,22.1,Impaired quality of life,6,17193011
0,22.1,Alopecia,3,17193015
0,22.1,Alopecia,3,17193026
0,22.1,Lumbar vertebral fracture,6,17193067
0,22.1,Acute kidney injury,1,17193090
1,22.1,Colitis,1,17193090
0,22.1,Pyrexia,1,17193091
0,22.1,Pancreatitis acute,6,17193136
0,22.1,Anaphylactic shock,1,17193140
0,22.1,Product dose omission,6,17193222
0,22.1,Lower respiratory tract infection,1,17193242
1,22.1,Sepsis,1,17193242
2,22.1,Arthropathy,2,17193242
3,22.1,Haemothorax,1,17193242
4,22.1,Pneumonia,1,17193242
0,22.1,Metastases to lung,6,17193329
1,22.1,Malignant neoplasm progression,6,17193329
2,22.1,Pericardial effusion,1,17193329
3,22.1,Non-small cell lung cancer,6,17193329
4,22.1,Metastases to bone,6,17193329
0,22.1,Weight increased,6,17193349
1,22.1,Feeling cold,1,17193349
2,22.1,Mental disorder,6,17193349
3,22.1,Sensitivity to weather change,6,17193349
4,22.1,Blood glucose fluctuation,3,17193349
5,22.1,Dyspepsia,1,17193349
6,22.1,Malaise,6,17193349
7,22.1,Dry mouth,2,17193349
8,22.1,Dyspnoea,6,17193349
9,22.1,Nausea,6,17193349
10,22.1,Nausea,6,17193349
11,22.1,Pruritus,6,17193349
12,22.1,Nasopharyngitis,1,17193349
13,22.1,Central venous catheterisation,6,17193349
14,22.1,Increased appetite,6,17193349
15,22.1,Decreased appetite,1,17193349
16,22.1,Pain,6,17193349
17,22.1,Dry mouth,6,17193349
18,22.1,Pain in extremity,6,17193349
19,22.1,Chest pain,1,17193349
20,22.1,Anxiety,6,17193349
21,22.1,Depressed mood,6,17193349
22,22.1,Skin wound,6,17193349
23,22.1,Panic reaction,6,17193349
24,22.1,Apathy,6,17193349
25,22.1,Flatulence,6,17193349
26,22.1,Feeling abnormal,6,17193349
27,22.1,Pain,1,17193349
28,22.1,Dry eye,1,17193349
29,22.1,Back pain,6,17193349
30,22.1,Fatigue,2,17193349
31,22.1,Pruritus,2,17193349
32,22.1,Insomnia,6,17193349
33,22.1,Blood pressure fluctuation,6,17193349
34,22.1,Hypotension,6,17193349
35,22.1,Pain,6,17193349
36,22.1,Dry mouth,1,17193349
37,22.1,Fatigue,6,17193349
38,22.1,Malignant neoplasm progression,6,17193349
39,22.1,Adverse drug reaction,6,17193349
40,22.1,Muscular weakness,6,17193349
41,22.1,Fatigue,1,17193349
42,22.1,Dizziness,1,17193349
43,22.1,Nausea,1,17193349
44,22.1,Arthritis,3,17193349
45,22.1,Nasopharyngitis,6,17193349
46,22.1,Peripheral swelling,6,17193349
47,22.1,Discomfort,1,17193349
48,22.1,Dizziness,6,17193349
49,22.1,Arthralgia,3,17193349
50,22.1,Constipation,1,17193349
51,22.1,Chest tube insertion,6,17193349
52,22.1,Agitation,6,17193349
53,22.1,Abdominal discomfort,1,17193349
54,22.1,Malaise,1,17193349
55,22.1,Headache,6,17193349
56,22.1,Fatigue,1,17193349
57,22.1,Product use in unapproved indication,6,17193349
58,22.1,Pericardial effusion,6,17193349
59,22.1,Malignant pleural effusion,6,17193349
60,22.1,Nervousness,6,17193349
61,22.1,Negative thoughts,6,17193349
62,22.1,Feeling abnormal,1,17193349
63,22.1,Obsessive-compulsive disorder,6,17193349
64,22.1,Taste disorder,6,17193349
65,22.1,Taste disorder,6,17193349
66,22.1,Poor quality sleep,6,17193349
67,22.1,Insomnia,6,17193349
68,22.1,Dyspnoea,6,17193349
69,22.1,Arthritis,6,17193349
70,22.1,Constipation,6,17193349
71,22.1,Nausea,6,17193349
72,22.1,Inappropriate schedule of product administration,6,17193349
0,22.1,Off label use,6,17193459
1,22.1,Rash,2,17193459
0,22.1,Pyrexia,1,17193476
1,22.1,Muscular weakness,1,17193476
0,22.1,Device leakage,,17193539
1,22.1,Wrong technique in product usage process,,17193539
2,22.1,Syringe issue,,17193539
3,22.1,Product preparation error,,17193539
0,22.1,Hyperhidrosis,6,17193547
1,22.1,Insomnia,6,17193547
2,22.1,Incorrect route of product administration,6,17193547
3,22.1,Fatigue,6,17193547
4,22.1,Hot flush,6,17193547
0,22.1,Malignant neoplasm progression,6,17193548
1,22.1,Diarrhoea,6,17193548
0,22.1,Langerhans^ cell histiocytosis,6,17193551
0,22.1,Abdominal distension,1,17193577
0,22.1,Neoplasm progression,6,17193599
1,22.1,Neutropenia,6,17193599
0,22.1,Malignant neoplasm progression,5,17193656
0,22.1,Anaemia,1,17193669
1,22.1,Haemoglobin decreased,1,17193669
2,22.1,White blood cell count decreased,1,17193669
3,22.1,Neutrophil count decreased,1,17193669
0,22.1,Sarcoidosis,6,17193682
0,22.1,Decreased immune responsiveness,2,17193771
1,22.1,Haemoglobin decreased,3,17193771
0,22.1,Acute kidney injury,1,17193785
0,22.1,Nausea,1,17193806
1,22.1,Chills,1,17193806
2,22.1,Back pain,1,17193806
3,22.1,Hypertension,1,17193806
4,22.1,Tremor,1,17193806
0,22.1,Hypertensive crisis,2,17193807
0,22.1,Product use in unapproved indication,6,17193843
1,22.1,Paranasal sinus hypersecretion,6,17193843
2,22.1,Cough,3,17193843
3,22.1,Weight decreased,6,17193843
4,22.1,Dysphonia,3,17193843
5,22.1,Hypoaesthesia,1,17193843
0,22.1,Drug ineffective,6,17193906
1,22.1,Gastrointestinal vascular malformation haemorrhagic,6,17193906
2,22.1,Malignant neoplasm progression,6,17193906
0,22.1,Rectal haemorrhage,2,17193985
1,22.1,Melaena,2,17193985
2,22.1,Immune thrombocytopenic purpura,1,17193985
3,22.1,Haemoglobin decreased,2,17193985
0,22.1,Hyperbilirubinaemia,6,17194015
0,22.1,Product use in unapproved indication,6,17194031
1,22.1,Fatigue,6,17194031
2,22.1,Dermatitis,6,17194031
3,22.1,Nausea,6,17194031
0,22.1,Oedema peripheral,6,17194034
1,22.1,Drug-induced liver injury,5,17194034
2,22.1,Pneumonia,2,17194034
3,22.1,Haemorrhage subcutaneous,6,17194034
4,22.1,Cholangitis sclerosing,5,17194034
5,22.1,Blood pressure decreased,6,17194034
6,22.1,Hypothyroidism,6,17194034
0,22.1,Intentional product use issue,6,17194053
1,22.1,Adverse event,6,17194053
0,22.1,Bone marrow failure,2,17194058
0,22.1,Granuloma,1,17194061
1,22.1,Sarcoidosis,1,17194061
0,22.1,Disease progression,5,17194070
1,22.1,Therapeutic product effect decreased,6,17194070
0,22.1,Asthenia,5,17194077
1,22.1,Product use in unapproved indication,6,17194077
2,22.1,Confusional state,5,17194077
3,22.1,Spinal pain,5,17194077
4,22.1,Encephalitis,5,17194077
5,22.1,Meningitis viral,5,17194077
6,22.1,Diplegia,5,17194077
0,22.1,Death,5,17194111
0,22.1,Neutrophil count decreased,6,17194118
1,22.1,Anaemia,6,17194118
0,22.1,Monoplegia,3,17194134
1,22.1,Fatigue,3,17194134
2,22.1,Pain,3,17194134
3,22.1,Dyspnoea,3,17194134
4,22.1,Adverse reaction,3,17194134
0,22.1,Dehydration,3,17194154
1,22.1,Dysgeusia,3,17194154
2,22.1,Vomiting,3,17194154
3,22.1,Diarrhoea,3,17194154
4,22.1,Hypokalaemia,3,17194154
5,22.1,Oedema peripheral,3,17194154
6,22.1,Abdominal pain,3,17194154
7,22.1,Dysuria,3,17194154
8,22.1,Hyperglycaemia,3,17194154
9,22.1,Nail disorder,3,17194154
10,22.1,Pneumonitis,3,17194154
11,22.1,Hypocalcaemia,3,17194154
0,22.1,Pancytopenia,1,17194175
0,22.1,Interstitial lung disease,1,17194181
0,22.1,Urticaria,1,17194182
1,22.1,Erythema,1,17194182
2,22.1,Flushing,1,17194182
3,22.1,Throat tightness,1,17194182
4,22.1,Dysphonia,1,17194182
0,22.1,Renal failure,5,17194183
1,22.1,Cardiac failure,5,17194183
2,22.1,Suspected counterfeit product,5,17194183
0,22.1,Herpes simplex encephalitis,6,17194193
1,22.1,White blood cell count increased,6,17194193
2,22.1,Headache,6,17194193
3,22.1,Protein total increased,6,17194193
4,22.1,Asthenia,6,17194193
5,22.1,Platelet count decreased,6,17194193
0,22.1,Dyspnoea,6,17194239
1,22.1,Loss of consciousness,6,17194239
2,22.1,Hyperhidrosis,6,17194239
0,22.1,Malaise,1,17194250
0,22.1,Off label use,6,17194309
1,22.1,Death,5,17194309
2,22.1,Intentional product use issue,6,17194309
0,22.1,Nausea,1,17194323
1,22.1,Fatigue,1,17194323
2,22.1,Nausea,1,17194323
3,22.1,Malaise,1,17194323
4,22.1,Prostatic specific antigen increased,3,17194323
0,22.1,Decreased appetite,1,17194327
1,22.1,Prerenal failure,6,17194327
2,22.1,Infection,6,17194327
3,22.1,Postrenal failure,6,17194327
4,22.1,Metastases to peritoneum,3,17194327
5,22.1,Diarrhoea,1,17194327
6,22.1,C-reactive protein increased,6,17194327
7,22.1,Subileus,3,17194327
0,22.1,Facial paralysis,6,17194330
1,22.1,Reduced facial expression,6,17194330
2,22.1,Facial nerve disorder,6,17194330
0,22.1,Loss of consciousness,6,17194333
1,22.1,Laboratory test abnormal,6,17194333
2,22.1,Malaise,6,17194333
3,22.1,Hypertension,6,17194333
4,22.1,Insomnia,6,17194333
5,22.1,Asthenia,6,17194333
0,22.1,Overdose,6,17194377
1,22.1,Off label use,6,17194377
2,22.1,Colorectal cancer metastatic,6,17194377
3,22.1,Gene mutation,6,17194377
0,22.1,Epistaxis,6,17194403
1,22.1,Hydronephrosis,6,17194403
2,22.1,Asthenia,1,17194403
0,22.1,Diabetic ketoacidosis,6,17194411
1,22.1,Autoantibody positive,6,17194411
2,22.1,Blood glucose increased,6,17194411
3,22.1,Thirst,6,17194411
4,22.1,Metabolic acidosis,6,17194411
5,22.1,Oral candidiasis,6,17194411
6,22.1,Oral pain,6,17194411
7,22.1,Herpes zoster,6,17194411
8,22.1,Type 1 diabetes mellitus,6,17194411
9,22.1,Altered state of consciousness,1,17194411
0,22.1,Malaise,6,17194431
1,22.1,Gastric disorder,3,17194431
2,22.1,Asthenia,3,17194431
3,22.1,Vitamin D deficiency,3,17194431
4,22.1,Weight decreased,3,17194431
5,22.1,Decreased appetite,3,17194431
6,22.1,Depression,3,17194431
7,22.1,Pulmonary embolism,1,17194431
0,22.1,Disease progression,5,17194454
1,22.1,Metastases to lung,6,17194454
2,22.1,Haematotoxicity,6,17194454
3,22.1,Gastrointestinal disorder,6,17194454
4,22.1,Disease recurrence,6,17194454
0,22.1,Acidosis hyperchloraemic,2,17194504
1,22.1,Physical deconditioning,2,17194504
2,22.1,Gastrointestinal disorder,2,17194504
3,22.1,Gastrointestinal anastomotic complication,2,17194504
4,22.1,Intentional product use issue,6,17194504
5,22.1,Faeces discoloured,2,17194504
6,22.1,Gastrointestinal ulcer haemorrhage,2,17194504
7,22.1,Rectal haemorrhage,2,17194504
8,22.1,Acute kidney injury,2,17194504
9,22.1,Diarrhoea,2,17194504
10,22.1,Feeding disorder,2,17194504
11,22.1,Weight decreased,2,17194504
12,22.1,Disseminated intravascular coagulation,2,17194504
13,22.1,Haemorrhage,2,17194504
0,22.1,Myalgia,2,17194557
1,22.1,Drug interaction,6,17194557
2,22.1,Musculoskeletal toxicity,2,17194557
3,22.1,Rhabdomyolysis,2,17194557
4,22.1,Muscular weakness,2,17194557
5,22.1,Pain in extremity,2,17194557
6,22.1,Arthralgia,2,17194557
7,22.1,Myopathy,2,17194557
8,22.1,Asthenia,2,17194557
0,22.1,Pancreatic carcinoma,6,17194566
0,22.1,Fatigue,1,17194579
1,22.1,Polyneuropathy,1,17194579
2,22.1,Colitis,1,17194579
0,22.1,General physical health deterioration,1,17194658
1,22.1,Headache,1,17194658
2,22.1,Pruritus,1,17194658
0,22.1,Malignant neoplasm progression,6,17194690
1,22.1,Fatigue,1,17194690
0,22.1,Neoplasm progression,6,17194719
1,22.1,Seizure,6,17194719
2,22.1,Condition aggravated,6,17194719
0,22.1,Neutrophil count decreased,6,17194727
1,22.1,Leukocytosis,6,17194727
0,22.1,Bacteraemia,1,17194768
1,22.1,Device related infection,1,17194768
0,22.1,Muscle spasms,,17194807
1,22.1,Chest discomfort,,17194807
0,22.1,Pain,6,17194809
1,22.1,Nausea,2,17194809
2,22.1,Vomiting,2,17194809
3,22.1,Diarrhoea,6,17194809
4,22.1,Febrile neutropenia,1,17194809
5,22.1,Hypophagia,6,17194809
6,22.1,Failure to thrive,6,17194809
0,22.1,Drug ineffective,6,17194815
0,22.1,Ovarian cancer recurrent,6,17194818
1,22.1,Malignant neoplasm progression,6,17194818
0,22.1,Jaundice,3,17194837
1,22.1,Autoimmune hepatitis,6,17194837
2,22.1,Bile duct obstruction,3,17194837
3,22.1,Malignant neoplasm progression,6,17194837
4,22.1,Biliary tract infection,6,17194837
0,22.1,Emotional distress,6,17194846
1,22.1,Depression,3,17194846
2,22.1,Fatigue,6,17194846
3,22.1,Blood count abnormal,6,17194846
4,22.1,Nervousness,3,17194846
5,22.1,Carbohydrate antigen 125 increased,3,17194846
0,22.1,Cough,6,17194867
1,22.1,Oxygen saturation decreased,6,17194867
2,22.1,Insomnia,1,17194867
3,22.1,Nasopharyngitis,6,17194867
4,22.1,Fatigue,3,17194867
5,22.1,Constipation,1,17194867
6,22.1,Asthenia,6,17194867
0,22.1,Dry mouth,6,17194869
1,22.1,Fatigue,6,17194869
2,22.1,Pelvic pain,6,17194869
3,22.1,Neuropathy peripheral,6,17194869
4,22.1,Stomatitis,6,17194869
5,22.1,Blood pressure increased,6,17194869
6,22.1,Heart rate increased,6,17194869
7,22.1,Oral herpes,6,17194869
8,22.1,Candida infection,6,17194869
0,22.1,Transfusion,6,17194870
1,22.1,Nausea,6,17194870
2,22.1,Anaemia,6,17194870
0,22.1,Therapy cessation,,17194873
1,22.1,Nephrolithiasis,,17194873
0,22.1,Unevaluable event,1,17194888
1,22.1,Urinary retention,1,17194888
0,22.1,Hypersensitivity,1,17194998
0,22.1,Blood cholesterol increased,3,17195037
1,22.1,Hepatic function abnormal,3,17195037
2,22.1,Influenza like illness,3,17195037
3,22.1,White blood cell count decreased,3,17195037
4,22.1,Blood pressure decreased,3,17195037
5,22.1,Bone pain,3,17195037
6,22.1,Chills,3,17195037
7,22.1,Dehydration,3,17195037
8,22.1,Dizziness,3,17195037
9,22.1,Feeling hot,3,17195037
10,22.1,Gamma-glutamyltransferase decreased,3,17195037
11,22.1,Peripheral swelling,3,17195037
12,22.1,Rash,3,17195037
13,22.1,Road traffic accident,3,17195037
14,22.1,Vasodilatation,3,17195037
15,22.1,Abdominal distension,3,17195037
16,22.1,Arthralgia,3,17195037
17,22.1,Asthenia,3,17195037
18,22.1,Blood potassium increased,3,17195037
19,22.1,Drug hypersensitivity,3,17195037
20,22.1,Hypoaesthesia,3,17195037
21,22.1,Peripheral coldness,3,17195037
22,22.1,Abdominal discomfort,3,17195037
23,22.1,Chest pain,3,17195037
24,22.1,Contusion,3,17195037
25,22.1,Gastritis,3,17195037
26,22.1,Impaired healing,3,17195037
27,22.1,Injection site bruising,3,17195037
28,22.1,Migraine,3,17195037
29,22.1,Pain,3,17195037
30,22.1,Pain in jaw,3,17195037
31,22.1,Paraesthesia,3,17195037
32,22.1,Vein disorder,3,17195037
33,22.1,Blood creatinine decreased,3,17195037
34,22.1,Body temperature decreased,3,17195037
35,22.1,Feeling cold,3,17195037
36,22.1,Incontinence,3,17195037
37,22.1,Infusion site haemorrhage,3,17195037
38,22.1,Mean cell haemoglobin decreased,3,17195037
39,22.1,Neutrophil count decreased,3,17195037
40,22.1,Oedema peripheral,3,17195037
41,22.1,Pain in extremity,3,17195037
42,22.1,Post-traumatic neck syndrome,3,17195037
43,22.1,Retinal detachment,3,17195037
44,22.1,Urticaria,3,17195037
45,22.1,Abdominal pain upper,3,17195037
46,22.1,Anxiety,3,17195037
47,22.1,Fatigue,3,17195037
48,22.1,Flushing,3,17195037
49,22.1,Headache,3,17195037
50,22.1,Immunodeficiency,3,17195037
51,22.1,Infusion site pain,3,17195037
52,22.1,Injection site erythema,3,17195037
53,22.1,Injection site mass,3,17195037
54,22.1,Muscle spasms,3,17195037
55,22.1,Platelet count decreased,3,17195037
56,22.1,Pyrexia,3,17195037
57,22.1,Skin sensitisation,3,17195037
58,22.1,Decreased appetite,3,17195037
59,22.1,Infusion site coldness,3,17195037
60,22.1,Infusion site induration,3,17195037
61,22.1,Nausea,3,17195037
62,22.1,Poor venous access,3,17195037
63,22.1,Spinal pain,3,17195037
64,22.1,Toothache,3,17195037
65,22.1,Back pain,3,17195037
66,22.1,Drug ineffective,3,17195037
67,22.1,Injection site swelling,3,17195037
68,22.1,Malaise,3,17195037
69,22.1,Metastases to bone,3,17195037
70,22.1,Tooth disorder,3,17195037
0,22.1,Back pain,1,17195083
1,22.1,Dyspnoea,3,17195083
2,22.1,Emphysema,1,17195083
3,22.1,Breast cancer metastatic,5,17195083
4,22.1,Femoral neck fracture,3,17195083
5,22.1,Multiple organ dysfunction syndrome,5,17195083
6,22.1,Malignant neoplasm progression,5,17195083
7,22.1,Cough,3,17195083
0,22.1,Body temperature increased,6,17195162
1,22.1,Chills,6,17195162
2,22.1,Death,5,17195162
3,22.1,Cardiac arrest,6,17195162
0,22.1,Leukopenia,1,17195209
1,22.1,Mucosal inflammation,1,17195209
2,22.1,Malignant neoplasm progression,5,17195209
0,22.1,Malignant neoplasm progression,5,17195218
1,22.1,Muscular weakness,1,17195218
2,22.1,Diarrhoea,1,17195218
3,22.1,Vomiting,1,17195218
4,22.1,Vision blurred,1,17195218
5,22.1,Vertigo,1,17195218
6,22.1,White blood cell count decreased,1,17195218
7,22.1,Fatigue,1,17195218
8,22.1,Vomiting,1,17195218
0,22.1,Chills,1,17195246
1,22.1,Feeling abnormal,1,17195246
2,22.1,Body temperature increased,1,17195246
3,22.1,Uveitis,1,17195246
4,22.1,Tremor,1,17195246
5,22.1,Pain,1,17195246
0,22.1,Fatigue,6,17195374
1,22.1,Malignant neoplasm progression,6,17195374
2,22.1,Asthenia,6,17195374
3,22.1,Neutropenia,6,17195374
4,22.1,Tumour marker increased,6,17195374
5,22.1,Pain,6,17195374
0,22.1,Anxiety,1,17195395
1,22.1,Erythema,1,17195395
0,22.1,Cardio-respiratory arrest,5,17195400
1,22.1,Dyspnoea,5,17195400
2,22.1,Pneumonia,5,17195400
3,22.1,Drug interaction,6,17195400
0,22.1,Malaise,5,17195415
1,22.1,Pulmonary embolism,5,17195415
2,22.1,Acute respiratory distress syndrome,5,17195415
3,22.1,Multiple organ dysfunction syndrome,5,17195415
0,22.1,Abdominal pain upper,1,17195430
1,22.1,Diarrhoea,1,17195430
2,22.1,Neuropathy peripheral,3,17195430
3,22.1,Dysuria,1,17195430
4,22.1,Nausea,1,17195430
5,22.1,Vulvovaginal inflammation,1,17195430
6,22.1,Rhinorrhoea,1,17195430
7,22.1,Vomiting,1,17195430
8,22.1,Asthenia,1,17195430
0,22.1,Hypokalaemia,3,17195453
1,22.1,Dysuria,3,17195453
2,22.1,Hyperglycaemia,3,17195453
3,22.1,Dehydration,3,17195453
4,22.1,Dysgeusia,3,17195453
5,22.1,Nail disorder,3,17195453
6,22.1,Oedema peripheral,3,17195453
7,22.1,Abdominal pain,3,17195453
8,22.1,Hypocalcaemia,3,17195453
9,22.1,Vomiting,3,17195453
10,22.1,Diarrhoea,3,17195453
11,22.1,Pneumonitis,3,17195453
0,22.1,Malignant neoplasm progression,6,17195460
0,22.1,Death,,17195465
0,22.1,Transaminases increased,2,17195523
1,22.1,Liver disorder,2,17195523
2,22.1,Blood bilirubin increased,2,17195523
0,22.1,Dehydration,,17195544
1,22.1,Skin exfoliation,,17195544
0,22.1,Liver disorder,2,17195556
1,22.1,Transaminases increased,2,17195556
2,22.1,Blood bilirubin increased,2,17195556
0,22.1,Encephalitis,1,17195560
1,22.1,Hyperammonaemia,1,17195560
0,22.1,Pancytopenia,6,17195570
1,22.1,Metastases to central nervous system,6,17195570
0,22.1,Cataplexy,1,17195590
0,22.1,Diarrhoea,,17195606
0,22.1,Hyponatraemia,1,17195627
1,22.1,Decreased appetite,1,17195627
2,22.1,Prostatic specific antigen increased,6,17195627
0,22.1,Renal stone removal,,17195644
0,22.1,Transaminases increased,1,17195662
0,22.1,Death,5,17195668
0,22.1,Death,,17195675
0,22.1,White blood cell count decreased,6,17195676
1,22.1,Platelet count decreased,2,17195676
0,22.1,Rash erythematous,1,17195744
1,22.1,Presyncope,1,17195744
2,22.1,Loss of consciousness,1,17195744
0,22.1,Cardio-respiratory arrest,5,17195770
0,22.1,Death,5,17195775
0,22.1,Ileus,,17195792
0,22.1,Ileus,,17195793
0,22.1,Cholangitis,,17195794
0,22.1,Pulmonary embolism,5,17195808
0,22.1,Malignant neoplasm progression,6,17195830
0,22.1,Acute kidney injury,,17195836
0,22.1,Decreased appetite,6,17195837
1,22.1,Product use in unapproved indication,,17195837
2,22.1,Neuropathy peripheral,6,17195837
3,22.1,Overdose,,17195837
4,22.1,Taste disorder,6,17195837
5,22.1,Off label use,,17195837
0,22.1,Neutropenia,1,17195899
0,22.1,Weight increased,6,17195936
1,22.1,Fatigue,3,17195936
2,22.1,Carbohydrate antigen 125 increased,3,17195936
3,22.1,Product dose omission,6,17195936
4,22.1,Vomiting,6,17195936
5,22.1,Nausea,6,17195936
6,22.1,Malaise,1,17195936
7,22.1,Retching,1,17195936
8,22.1,Fluid replacement,1,17195936
9,22.1,Abdominal discomfort,6,17195936
10,22.1,Lymphocyte count decreased,6,17195936
0,22.1,Cerebral disorder,3,17195955
1,22.1,Meningitis,3,17195955
2,22.1,Substance-induced psychotic disorder,3,17195955
0,22.1,Hot flush,2,17195958
1,22.1,Fatigue,6,17195958
2,22.1,Intestinal resection,2,17195958
3,22.1,Spinal osteoarthritis,3,17195958
0,22.1,Dyspnoea,2,17195966
1,22.1,Asthenia,3,17195966
2,22.1,Wrong technique in product usage process,,17195966
3,22.1,Somnolence,3,17195966
0,22.1,General physical health deterioration,,17196069
1,22.1,Malaise,2,17196069
2,22.1,Weight decreased,2,17196069
3,22.1,Fall,2,17196069
4,22.1,Balance disorder,2,17196069
5,22.1,Agraphia,2,17196069
6,22.1,Nausea,2,17196069
0,22.1,Peripheral motor neuropathy,6,17196079
1,22.1,Sitting disability,6,17196079
2,22.1,Peripheral sensory neuropathy,6,17196079
3,22.1,Unmasking of previously unidentified disease,6,17196079
0,22.1,Terminal state,6,17196107
0,22.1,Varicose vein,2,17196143
1,22.1,Venoocclusive liver disease,6,17196143
2,22.1,Varices oesophageal,2,17196143
3,22.1,Portal hypertension,6,17196143
0,22.1,Blood urine present,3,17196165
0,22.1,Hypertension,1,17196166
0,22.1,Dysaesthesia,1,17196183
1,22.1,General physical health deterioration,6,17196183
0,22.1,Death,5,17196190
1,22.1,Suspected counterfeit product,5,17196190
0,22.1,Off label use,6,17196283
1,22.1,Product use in unapproved indication,5,17196283
2,22.1,Immune-mediated pneumonitis,3,17196283
3,22.1,General physical health deterioration,5,17196283
4,22.1,Therapy non-responder,6,17196283
0,22.1,Therapeutic product effect incomplete,6,17196371
1,22.1,Toxicity to various agents,6,17196371
0,22.1,Death,5,17196390
0,22.1,Aphthous ulcer,6,17196430
0,22.1,Fatigue,6,17196439
0,22.1,Abdominal pain,6,17196441
1,22.1,Blood bilirubin increased,1,17196441
2,22.1,Gallbladder rupture,6,17196441
0,22.1,Surgery,6,17196460
1,22.1,Eye operation,6,17196460
0,22.1,Throat tightness,1,17196500
1,22.1,Feeling hot,1,17196500
2,22.1,Cough,1,17196500
0,22.1,Retinopathy,6,17196606
0,22.1,Pneumonia,4,17196622
1,22.1,Muscle spasms,6,17196622
2,22.1,Fatigue,6,17196622
3,22.1,Somnolence,6,17196622
4,22.1,Product dose omission,3,17196622
0,22.1,Facial paralysis,6,17196646
0,22.1,Cholangitis,1,17196677
1,22.1,Sepsis,5,17196677
0,22.1,Diarrhoea,3,17196680
1,22.1,Colitis,3,17196680
2,22.1,Abdominal pain,3,17196680
0,22.1,Death,5,17196693
0,22.1,Colitis,3,17196695
0,22.1,Diarrhoea,1,17196698
1,22.1,Proctitis,1,17196698
2,22.1,Abdominal pain,1,17196698
3,22.1,Intestinal obstruction,1,17196698
0,22.1,Mean cell volume increased,3,17196699
1,22.1,Protein urine present,3,17196699
2,22.1,Proteinuria,3,17196699
3,22.1,Pyrexia,3,17196699
4,22.1,Lymphocyte count decreased,3,17196699
5,22.1,Mean cell haemoglobin concentration decreased,3,17196699
6,22.1,Blood magnesium decreased,3,17196699
7,22.1,Eosinophil count decreased,3,17196699
8,22.1,Oxygen saturation decreased,3,17196699
9,22.1,Red blood cell count decreased,3,17196699
10,22.1,Red cell distribution width increased,3,17196699
11,22.1,White blood cell count decreased,3,17196699
12,22.1,General physical health deterioration,3,17196699
13,22.1,Urine protein/creatinine ratio increased,3,17196699
14,22.1,Haemoglobin decreased,3,17196699
15,22.1,Neutrophil count decreased,3,17196699
16,22.1,Alanine aminotransferase increased,3,17196699
17,22.1,Blood creatinine increased,3,17196699
18,22.1,Haematocrit decreased,3,17196699
19,22.1,Platelet count decreased,3,17196699
20,22.1,Renal failure,3,17196699
21,22.1,Aspartate aminotransferase increased,3,17196699
0,22.1,Neoplasm progression,5,17196707
1,22.1,Thalamus haemorrhage,5,17196707
2,22.1,Cytopenia,6,17196707
0,22.1,Gastric cancer,5,17196737
0,22.1,Death,5,17196758
0,22.1,Second primary malignancy,6,17196848
1,22.1,Acute leukaemia,6,17196848
0,22.1,Thrombocytopenia,6,17196860
1,22.1,Therapy partial responder,6,17196860
2,22.1,Neurotoxicity,6,17196860
3,22.1,Neutropenia,6,17196860
0,22.1,Platelet count decreased,2,17196868
0,22.1,Posterior reversible encephalopathy syndrome,4,17196871
0,22.1,Urinary tract infection,6,17196940
1,22.1,Malaise,2,17196940
2,22.1,C-reactive protein increased,1,17196940
3,22.1,Rash,1,17196940
4,22.1,Pyrexia,1,17196940
5,22.1,Loss of consciousness,1,17196940
0,22.1,Osteonecrosis,2,17197174
1,22.1,Abscess,2,17197174
2,22.1,Pain,2,17197174
0,22.1,Malignant neoplasm progression,6,17197180
0,22.1,Abscess limb,1,17197205
0,22.1,Cardiomyopathy,2,17197238
1,22.1,Cardiac failure acute,2,17197238
0,22.1,Rectal cancer stage II,6,17197283
0,22.1,Mastitis,3,17197299
0,22.1,Mucosal toxicity,1,17197332
1,22.1,Diarrhoea,1,17197332
0,22.1,Anaphylactic shock,1,17197337
1,22.1,Angina pectoris,1,17197337
2,22.1,Hypotension,1,17197337
3,22.1,Skin test positive,1,17197337
4,22.1,Bronchospasm,1,17197337
5,22.1,Cyanosis central,1,17197337
6,22.1,Tachycardia,1,17197337
7,22.1,Seizure,1,17197337
8,22.1,Stridor,1,17197337
9,22.1,Oxygen saturation immeasurable,1,17197337
10,22.1,Dyspnoea,1,17197337
11,22.1,Urticaria,1,17197337
12,22.1,Akathisia,1,17197337
0,22.1,Malignant neoplasm progression,6,17197339
1,22.1,Metastases to lung,6,17197339
0,22.1,Metastases to lung,6,17197373
1,22.1,Malignant neoplasm progression,5,17197373
2,22.1,Intestinal metastasis,6,17197373
3,22.1,Anaemia,6,17197373
4,22.1,Haematochezia,6,17197373
0,22.1,Metastases to bone,6,17197379
1,22.1,Treatment failure,6,17197379
2,22.1,Malignant neoplasm progression,6,17197379
3,22.1,Metastases to central nervous system,6,17197379
4,22.1,Metastases to skin,6,17197379
0,22.1,Brain neoplasm,5,17197382
1,22.1,Pruritus,3,17197382
2,22.1,Lung neoplasm,6,17197382
3,22.1,Adrenal neoplasm,6,17197382
4,22.1,Pyrexia,6,17197382
5,22.1,Malignant neoplasm progression,5,17197382
6,22.1,Appetite disorder,3,17197382
7,22.1,Drug resistance,5,17197382
8,22.1,Intracranial pressure increased,6,17197382
9,22.1,Coma,6,17197382
0,22.1,Product use in unapproved indication,6,17197384
1,22.1,Abscess,6,17197384
0,22.1,Chronic obstructive pulmonary disease,4,17197436
1,22.1,Chronic obstructive pulmonary disease,1,17197436
0,22.1,Injection site pain,3,17197482
1,22.1,Injection site induration,3,17197482
0,22.1,Metastases to bone,,17197486
0,22.1,Product monitoring error,6,17197488
0,22.1,Metastases to bone,6,17197503
1,22.1,Prostatic specific antigen increased,6,17197503
0,22.1,Injection site pain,6,17197510
1,22.1,Injection site erythema,6,17197510
0,22.1,Cardiogenic shock,5,17197576
1,22.1,Myocarditis,5,17197576
0,22.1,Dyspnoea,6,17197655
0,22.1,Hyperkalaemia,1,17197687
1,22.1,Anaemia,2,17197687
0,22.1,Gout,3,17197743
1,22.1,Oral mucosal blistering,6,17197743
2,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,17197743
3,22.1,Diarrhoea,6,17197743
4,22.1,Dehydration,6,17197743
5,22.1,Blood pressure increased,2,17197743
6,22.1,Rectal haemorrhage,6,17197743
7,22.1,Nausea,6,17197743
0,22.1,Death,5,17197781
1,22.1,Abdominal pain upper,3,17197781
0,22.1,Fatigue,3,17197796
1,22.1,Decreased appetite,3,17197796
0,22.1,Impaired self-care,6,17197804
1,22.1,Injection site infection,6,17197804
2,22.1,Wound,1,17197804
3,22.1,Rash,6,17197804
4,22.1,Osteoarthritis,6,17197804
5,22.1,Arthropathy,6,17197804
6,22.1,Seroma,6,17197804
7,22.1,Dermatitis allergic,6,17197804
0,22.1,Sinus disorder,6,17197834
0,22.1,Malignant neoplasm progression,6,17197864
0,22.1,Syncope,3,17197871
1,22.1,Pallor,6,17197871
0,22.1,Death,5,17197872
0,22.1,Neuropathy peripheral,3,17197882
0,22.1,Platelet count decreased,1,17197884
1,22.1,Duodenal ulcer,1,17197884
2,22.1,White blood cell count decreased,3,17197884
3,22.1,Cardiac failure,5,17197884
4,22.1,Gastritis,1,17197884
5,22.1,Atrial fibrillation,1,17197884
6,22.1,Anaemia,1,17197884
7,22.1,Platelet count decreased,1,17197884
8,22.1,Cardiac failure,1,17197884
9,22.1,White blood cell count decreased,1,17197884
10,22.1,White blood cell count decreased,3,17197884
11,22.1,Oesophagitis,1,17197884
12,22.1,Urinary tract infection,3,17197884
13,22.1,Neutrophil count decreased,1,17197884
0,22.1,Bone marrow failure,2,17197920
0,22.1,General physical health deterioration,1,17197944
0,22.1,Jaundice cholestatic,2,17197982
0,22.1,Peripheral swelling,1,17198014
1,22.1,Feeling hot,1,17198014
2,22.1,Lymphoedema,6,17198014
3,22.1,Cellulitis,6,17198014
4,22.1,Deep vein thrombosis,6,17198014
5,22.1,Erythema,1,17198014
0,22.1,Hepatic cirrhosis,6,17198028
1,22.1,Hepatic steatosis,6,17198028
2,22.1,Alanine aminotransferase increased,6,17198028
3,22.1,Nonalcoholic fatty liver disease,6,17198028
4,22.1,Hepatic fibrosis,6,17198028
5,22.1,Prostate cancer,6,17198028
0,22.1,Femur fracture,1,17198117
1,22.1,Fall,1,17198117
2,22.1,Fatigue,1,17198117
0,22.1,Haematochezia,5,17198118
1,22.1,Rectal ulcer haemorrhage,5,17198118
2,22.1,Pneumonia aspiration,2,17198118
3,22.1,Thrombophlebitis migrans,3,17198118
4,22.1,Anaemia,5,17198118
5,22.1,Shock haemorrhagic,5,17198118
6,22.1,Interstitial lung disease,2,17198118
0,22.1,Hypertensive crisis,1,17198123
1,22.1,Pulmonary embolism,1,17198123
2,22.1,Pyrexia,1,17198123
0,22.1,Corneal epithelium defect,3,17198131
0,22.1,Dehydration,1,17198139
1,22.1,Anal haemorrhage,3,17198139
2,22.1,Device related thrombosis,2,17198139
3,22.1,Decreased appetite,3,17198139
4,22.1,Diarrhoea,3,17198139
5,22.1,Upper respiratory tract infection,1,17198139
6,22.1,Flatulence,3,17198139
7,22.1,Oropharyngeal pain,3,17198139
8,22.1,Dyspnoea,3,17198139
9,22.1,Nausea,3,17198139
10,22.1,Eructation,3,17198139
11,22.1,Cough,1,17198139
12,22.1,Abdominal pain upper,1,17198139
13,22.1,Dry mouth,3,17198139
14,22.1,Hypertension,3,17198139
15,22.1,Rectal tenesmus,3,17198139
16,22.1,Rash,3,17198139
17,22.1,Vomiting,3,17198139
18,22.1,Neutropenia,3,17198139
0,22.1,Concomitant disease aggravated,1,17198152
1,22.1,Hypokalaemia,1,17198152
2,22.1,Fatigue,1,17198152
3,22.1,Pleural effusion,1,17198152
4,22.1,Diarrhoea,3,17198152
5,22.1,Vision blurred,3,17198152
6,22.1,Blood pressure increased,1,17198152
7,22.1,Cutis laxa,1,17198152
8,22.1,Actinic elastosis,1,17198152
9,22.1,Basal cell carcinoma,1,17198152
0,22.1,Endometrial adenocarcinoma,4,17198198
0,22.1,Atrial tachycardia,4,17198260
1,22.1,Cardiac failure,4,17198260
0,22.1,Anaemia,6,17198289
0,22.1,Pneumocystis jirovecii pneumonia,2,17198344
0,22.1,Fall,1,17198376
1,22.1,Fracture,1,17198376
2,22.1,Hypotension,1,17198376
0,22.1,Polyneuropathy,3,17198391
0,22.1,Decreased appetite,6,17198403
1,22.1,Abdominal pain,6,17198403
2,22.1,General physical condition abnormal,6,17198403
3,22.1,Malignant neoplasm progression,6,17198403
0,22.1,Hypertension,1,17198415
1,22.1,Pruritus,1,17198415
2,22.1,Tachycardia,1,17198415
3,22.1,Flushing,1,17198415
4,22.1,Skin warm,1,17198415
0,22.1,Hyponatraemia,1,17198420
1,22.1,Seizure,1,17198420
2,22.1,Seizure,6,17198420
3,22.1,Hepatic enzyme increased,1,17198420
4,22.1,Hyponatraemia,6,17198420
0,22.1,Gastrointestinal disorder,6,17198430
1,22.1,White blood cell count decreased,6,17198430
2,22.1,Radiation proctitis,6,17198430
3,22.1,Cystitis radiation,6,17198430
0,22.1,Respiratory tract infection,1,17198432
1,22.1,Upper respiratory tract infection,1,17198432
0,22.1,Enteritis,5,17198439
1,22.1,Diarrhoea,5,17198439
2,22.1,Dehydration,5,17198439
3,22.1,Nausea,5,17198439
4,22.1,Asthenia,5,17198439
5,22.1,Thrombocytopenia,5,17198439
0,22.1,Toxic neuropathy,6,17198441
1,22.1,Intentional product use issue,6,17198441
2,22.1,Anaemia,6,17198441
0,22.1,Ascites,6,17198475
1,22.1,Malignant neoplasm progression,6,17198475
2,22.1,Dyspnoea,6,17198475
0,22.1,Chorea,3,17198562
1,22.1,Ischaemic stroke,1,17198562
2,22.1,Ballismus,3,17198562
0,22.1,Malaise,3,17198593
1,22.1,Respiratory tract infection,1,17198593
2,22.1,Nasal crusting,3,17198593
3,22.1,Constipation,3,17198593
4,22.1,Syncope,1,17198593
5,22.1,Neuropathy peripheral,3,17198593
6,22.1,Nasopharyngitis,3,17198593
7,22.1,Dysphonia,3,17198593
8,22.1,Anal haemorrhage,1,17198593
9,22.1,Proteinuria,3,17198593
10,22.1,Diarrhoea,1,17198593
11,22.1,Fatigue,3,17198593
12,22.1,Epistaxis,1,17198593
13,22.1,Stomatitis,1,17198593
0,22.1,Wrong technique in product usage process,6,17198667
1,22.1,Flushing,6,17198667
2,22.1,Stridor,6,17198667
0,22.1,Febrile bone marrow aplasia,1,17198682
1,22.1,Diarrhoea,1,17198682
0,22.1,Thrombocytopenia,6,17198690
1,22.1,Haematotoxicity,6,17198690
2,22.1,Renal impairment,2,17198690
3,22.1,Anaemia,3,17198690
0,22.1,Interstitial lung disease,2,17198695
0,22.1,Hyperglycaemia,2,17198707
0,22.1,Cognitive disorder,6,17198730
0,22.1,Malignant neoplasm progression,6,17198736
1,22.1,Pneumonitis,6,17198736
2,22.1,Acute myeloid leukaemia,5,17198736
0,22.1,Altered state of consciousness,6,17198751
1,22.1,Speech disorder,6,17198751
2,22.1,Metastases to meninges,5,17198751
3,22.1,Dysphagia,6,17198751
0,22.1,Takayasu^s arteritis,6,17198789
1,22.1,Hepatic function abnormal,6,17198789
2,22.1,Shock,6,17198789
3,22.1,C-reactive protein increased,6,17198789
4,22.1,Pyrexia,6,17198789
5,22.1,Renal failure,6,17198789
0,22.1,Death,5,17198843
0,22.1,Neutropenia,6,17198884
1,22.1,Hyponatraemia,6,17198884
0,22.1,Femur fracture,6,17198915
1,22.1,Intertrigo,3,17198915
2,22.1,Capillary disorder,3,17198915
3,22.1,Oral mucosal blistering,3,17198915
4,22.1,Vein disorder,3,17198915
5,22.1,Fall,6,17198915
6,22.1,Secretion discharge,3,17198915
7,22.1,Clavicle fracture,6,17198915
8,22.1,Purpura,3,17198915
9,22.1,Rash,3,17198915
10,22.1,Eczema,3,17198915
0,22.1,Nephrolithiasis,6,17198916
1,22.1,Influenza,6,17198916
2,22.1,Balance disorder,6,17198916
3,22.1,Headache,6,17198916
4,22.1,Diarrhoea,6,17198916
5,22.1,Adrenal mass,6,17198916
6,22.1,Memory impairment,6,17198916
7,22.1,Diverticulum,6,17198916
8,22.1,Axillary pain,6,17198916
9,22.1,Pain,6,17198916
10,22.1,Decreased immune responsiveness,6,17198916
11,22.1,Metastases to central nervous system,6,17198916
12,22.1,Urinary incontinence,6,17198916
13,22.1,Erythema,6,17198916
14,22.1,Arthralgia,6,17198916
15,22.1,Bone pain,6,17198916
16,22.1,Anaemia,6,17198916
17,22.1,Paraneoplastic syndrome,6,17198916
18,22.1,Nausea,1,17198916
19,22.1,Malaise,1,17198916
20,22.1,Myalgia,6,17198916
21,22.1,Fatigue,6,17198916
22,22.1,Herpes virus infection,6,17198916
23,22.1,Metastases to bone,6,17198916
24,22.1,Dysphonia,6,17198916
25,22.1,Cough,6,17198916
26,22.1,Dizziness,6,17198916
0,22.1,Meningioma,3,17198963
0,22.1,Drug ineffective,6,17198981
1,22.1,Malignant neoplasm progression,6,17198981
2,22.1,Gastrointestinal vascular malformation haemorrhagic,6,17198981
0,22.1,Anaemia,1,17199001
0,22.1,Livedo reticularis,1,17199062
1,22.1,Necrosis,6,17199062
2,22.1,Livedo reticularis,6,17199062
3,22.1,Haemorrhage,6,17199062
0,22.1,Colitis,4,17199076
1,22.1,Febrile neutropenia,4,17199076
2,22.1,Abdominal discomfort,4,17199076
0,22.1,Metastases to central nervous system,6,17199093
0,22.1,Intervertebral disc protrusion,6,17199172
1,22.1,Fall,6,17199172
2,22.1,Urinary tract infection,1,17199172
3,22.1,Poor personal hygiene,6,17199172
4,22.1,Arthralgia,6,17199172
0,22.1,Disorientation,6,17199182
1,22.1,Cerebral thrombosis,6,17199182
2,22.1,Myocardial infarction,6,17199182
3,22.1,Diarrhoea,6,17199182
4,22.1,Delirium,6,17199182
5,22.1,Memory impairment,6,17199182
0,22.1,Cholangitis,6,17199185
0,22.1,Neutropenia,6,17199237
0,22.1,Drug hypersensitivity,1,17199248
1,22.1,Neuropathy peripheral,3,17199248
0,22.1,Bone marrow failure,2,17199250
0,22.1,Cholecystitis,1,17199265
1,22.1,Nausea,1,17199265
2,22.1,Neutrophil count decreased,1,17199265
3,22.1,Fatigue,3,17199265
0,22.1,Enterocolitis,2,17199301
0,22.1,Acute polyneuropathy,6,17199314
0,22.1,Pneumothorax,2,17199319
1,22.1,Haemoptysis,6,17199319
0,22.1,Shock,5,17199324
0,22.1,Pleural effusion,5,17199336
0,22.1,Death,5,17199351
0,22.1,Metastases to bone,3,17199388
1,22.1,Anaemia,3,17199388
2,22.1,Chest discomfort,6,17199388
3,22.1,Pallor,6,17199388
0,22.1,Death,5,17199391
0,22.1,Deep vein thrombosis,5,17199397
0,22.1,Hypothyroidism,6,17199410
1,22.1,Hypoalbuminaemia,2,17199410
2,22.1,Drug eruption,2,17199410
3,22.1,Decreased appetite,2,17199410
4,22.1,Hypokalaemia,2,17199410
0,22.1,Rash,1,17199648
1,22.1,Pancytopenia,1,17199648
2,22.1,Stomatitis,1,17199648
3,22.1,Drug interaction,6,17199648
0,22.1,Mastectomy,6,17199689
0,22.1,Alanine aminotransferase increased,1,17199694
1,22.1,Aspartate aminotransferase increased,1,17199694
2,22.1,Hepatic enzyme increased,1,17199694
0,22.1,Eczema,6,17199842
1,22.1,CD4 lymphocytes decreased,6,17199842
0,22.1,Pneumonitis,2,17199843
1,22.1,Malignant neoplasm progression,5,17199843
2,22.1,Pleural effusion,3,17199843
3,22.1,Interstitial lung disease,2,17199843
0,22.1,Drug effective for unapproved indication,6,17199850
1,22.1,Asthenia,3,17199850
2,22.1,Night sweats,3,17199850
3,22.1,Pain,3,17199850
0,22.1,Cholangitis sclerosing,3,17199853
0,22.1,Headache,1,17199865
1,22.1,Chills,1,17199865
2,22.1,Hypertension,1,17199865
3,22.1,Immediate post-injection reaction,1,17199865
4,22.1,Hyperthermia,1,17199865
5,22.1,Malaise,1,17199865
6,22.1,Dyspnoea,1,17199865
7,22.1,Nausea,1,17199865
0,22.1,Cardiomyopathy,3,17199923
1,22.1,Ejection fraction decreased,3,17199923
0,22.1,Pancytopenia,1,17199924
0,22.1,Catheter placement,6,17199946
1,22.1,Disease progression,6,17199946
2,22.1,Weight decreased,6,17199946
3,22.1,Neoplasm,6,17199946
4,22.1,Unevaluable event,3,17199946
5,22.1,Device occlusion,6,17199946
6,22.1,Adverse reaction,6,17199946
7,22.1,Post procedural bile leak,6,17199946
8,22.1,Pyrexia,3,17199946
0,22.1,Decreased appetite,6,17199960
1,22.1,Fanconi syndrome,2,17199960
2,22.1,Taste disorder,6,17199960
0,22.1,Oesophageal varices haemorrhage,6,17199975
1,22.1,Anaemia,6,17199975
2,22.1,Melaena,6,17199975
0,22.1,Acute kidney injury,1,17199985
1,22.1,Diarrhoea,1,17199985
2,22.1,Vomiting,1,17199985
0,22.1,Gastric perforation,6,17199986
1,22.1,Pneumonia aspiration,5,17199986
0,22.1,Pneumonia,1,17200010
0,22.1,General physical health deterioration,1,17200027
1,22.1,Dyspnoea,6,17200027
2,22.1,Rash,6,17200027
3,22.1,Gastrointestinal infection,1,17200027
4,22.1,Nausea,1,17200027
5,22.1,Gastroenteritis,6,17200027
6,22.1,Dehydration,2,17200027
7,22.1,Syncope,1,17200027
8,22.1,Vomiting,1,17200027
0,22.1,Bronchospasm,6,17200083
1,22.1,Back pain,6,17200083
0,22.1,Off label use,6,17200084
1,22.1,Hepatic failure,6,17200084
2,22.1,Product use issue,6,17200084
0,22.1,Acute polyneuropathy,1,17200100
0,22.1,Infusion related reaction,1,17200117
1,22.1,Vomiting,1,17200117
2,22.1,Non-Hodgkin^s lymphoma,6,17200117
3,22.1,Feeling cold,1,17200117
4,22.1,Pyrexia,1,17200117
5,22.1,Drug eruption,3,17200117
0,22.1,Disease progression,6,17200155
1,22.1,Off label use,6,17200155
0,22.1,Fatigue,1,17200171
1,22.1,Ascites,3,17200171
2,22.1,Hernia,5,17200171
3,22.1,Melaena,5,17200171
4,22.1,Haematemesis,5,17200171
0,22.1,Erectile dysfunction,6,17200307
1,22.1,Insurance issue,6,17200307
2,22.1,Therapy cessation,6,17200307
0,22.1,Disease progression,6,17200309
0,22.1,Contusion,1,17200328
1,22.1,Fall,6,17200328
2,22.1,Infusion related reaction,1,17200328
3,22.1,Head injury,1,17200328
4,22.1,Loss of consciousness,1,17200328
5,22.1,Blood pressure decreased,1,17200328
6,22.1,Anaphylactic reaction,1,17200328
0,22.1,Vomiting,4,17200360
1,22.1,Nausea,4,17200360
0,22.1,Pain,6,17200367
1,22.1,Dyspnoea,6,17200367
2,22.1,Palpitations,6,17200367
3,22.1,Heart rate increased,6,17200367
4,22.1,Arthralgia,6,17200367
5,22.1,Muscle spasms,6,17200367
6,22.1,Oedema,6,17200367
7,22.1,Swelling,6,17200367
8,22.1,Neuralgia,6,17200367
9,22.1,Endometriosis,6,17200367
10,22.1,Nausea,6,17200367
11,22.1,Skin swelling,6,17200367
12,22.1,Pulmonary mass,6,17200367
13,22.1,Asthenia,6,17200367
14,22.1,Uterine disorder,6,17200367
15,22.1,Ecchymosis,6,17200367
16,22.1,Pelvic inflammatory disease,6,17200367
17,22.1,Vomiting,6,17200367
18,22.1,Cyst,6,17200367
19,22.1,Haemorrhage,6,17200367
20,22.1,Vision blurred,6,17200367
0,22.1,Gastrointestinal disorder,6,17200381
1,22.1,Cystitis radiation,6,17200381
2,22.1,White blood cell count decreased,6,17200381
3,22.1,Bone marrow failure,6,17200381
4,22.1,Radiation proctitis,6,17200381
0,22.1,Death,5,17200388
0,22.1,Neuropathy peripheral,3,17200433
0,22.1,Pachymeningitis,3,17200435
1,22.1,Rhabdomyolysis,6,17200435
2,22.1,Myositis,6,17200435
3,22.1,Blood creatine phosphokinase increased,1,17200435
0,22.1,Pneumonitis,1,17200436
1,22.1,Pulmonary embolism,1,17200436
2,22.1,Pneumonia,4,17200436
0,22.1,Blood creatinine increased,1,17200437
0,22.1,Visual impairment,1,17200440
1,22.1,Hypotension,1,17200440
2,22.1,Oxygen saturation decreased,1,17200440
3,22.1,Pruritus,1,17200440
4,22.1,Rash,1,17200440
0,22.1,Metastases to bone,6,17200449
1,22.1,Prostatic specific antigen increased,3,17200449
0,22.1,Intentional product use issue,6,17200458
1,22.1,Malignant neoplasm progression,5,17200458
0,22.1,Ascites,2,17200461
0,22.1,Disease recurrence,6,17200494
0,22.1,Faecaloma,1,17200506
1,22.1,Death,5,17200506
0,22.1,Diarrhoea,6,17200589
1,22.1,Dehydration,6,17200589
0,22.1,Off label use,6,17200632
1,22.1,Therapeutic product effect incomplete,6,17200632
2,22.1,Delirium,6,17200632
3,22.1,Product use in unapproved indication,6,17200632
4,22.1,Somnolence,6,17200632
0,22.1,Sepsis,1,17200662
1,22.1,Pneumonitis,1,17200662
2,22.1,Multiple organ dysfunction syndrome,1,17200662
3,22.1,Septic shock,1,17200662
0,22.1,Duodenal ulcer perforation,2,17200665
0,22.1,Febrile neutropenia,4,17200667
1,22.1,Abdominal discomfort,4,17200667
2,22.1,Colitis,4,17200667
0,22.1,Diarrhoea,6,17200675
1,22.1,Leukopenia,6,17200675
2,22.1,Hypertension,6,17200675
3,22.1,Proctitis,6,17200675
4,22.1,Myocardial infarction,6,17200675
5,22.1,Polyneuropathy,6,17200675
6,22.1,Haematotoxicity,6,17200675
7,22.1,Ectopic antidiuretic hormone secretion,6,17200675
0,22.1,Dysaesthesia,1,17200724
0,22.1,Vasculitis,5,17200736
1,22.1,Neutropenia,5,17200736
2,22.1,Renal failure,5,17200736
0,22.1,Ileus,6,17200739
1,22.1,Necrotising colitis,6,17200739
0,22.1,Myalgia,2,17200743
1,22.1,Pain in extremity,2,17200743
2,22.1,Arthralgia,2,17200743
3,22.1,Asthenia,2,17200743
4,22.1,Muscular weakness,2,17200743
5,22.1,Musculoskeletal toxicity,2,17200743
6,22.1,Drug interaction,6,17200743
7,22.1,Myopathy,2,17200743
8,22.1,Rhabdomyolysis,2,17200743
0,22.1,Gastrointestinal infection,1,17200767
0,22.1,Immune-mediated pneumonitis,5,17200773
0,22.1,Otitis media,3,17200866
0,22.1,Flatulence,1,17200892
1,22.1,Constipation,1,17200892
2,22.1,Product dispensing error,6,17200892
3,22.1,Diarrhoea,1,17200892
4,22.1,Malaise,1,17200892
5,22.1,Drug ineffective for unapproved indication,6,17200892
6,22.1,Bone pain,3,17200892
7,22.1,Abdominal pain upper,1,17200892
8,22.1,Fatigue,3,17200892
9,22.1,Hot flush,2,17200892
0,22.1,Neutropenia,2,17200923
0,22.1,Neoplasm progression,6,17200924
1,22.1,Bone marrow toxicity,2,17200924
2,22.1,Neutropenia,2,17200924
0,22.1,Dysphagia,6,17200936
1,22.1,Oesophageal haemorrhage,6,17200936
2,22.1,Hiccups,6,17200936
3,22.1,Cancer pain,6,17200936
4,22.1,Asthenia,6,17200936
0,22.1,Erythema,2,17200938
1,22.1,Dyspnoea,2,17200938
2,22.1,Sensation of foreign body,2,17200938
0,22.1,Neutrophil count decreased,1,17200951
0,22.1,Colitis,4,17200998
1,22.1,Diarrhoea,4,17200998
0,22.1,Alanine aminotransferase increased,3,17201045
1,22.1,Aspartate aminotransferase increased,3,17201045
0,22.1,Immune-mediated enterocolitis,1,17201055
1,22.1,Crohn^s disease,3,17201055
0,22.1,Headache,4,17201058
1,22.1,Neutropenia,4,17201058
2,22.1,Syncope,4,17201058
3,22.1,Dehydration,4,17201058
0,22.1,Sepsis,3,17201059
0,22.1,Mouth haemorrhage,2,17201060
1,22.1,Oral pain,2,17201060
2,22.1,Feeding disorder,2,17201060
3,22.1,Stomatitis,2,17201060
4,22.1,Stevens-Johnson syndrome,2,17201060
5,22.1,Rash,2,17201060
0,22.1,Contusion,3,17201081
0,22.1,Prostatic specific antigen increased,3,17201116
1,22.1,Therapy cessation,6,17201116
0,22.1,Suture rupture,6,17201181
0,22.1,Hepatitis acute,6,17201183
0,22.1,Hepatitis acute,6,17201184
0,22.1,Hepatitis acute,6,17201185
0,22.1,Hydronephrosis,6,17201188
1,22.1,Oedema,6,17201188
2,22.1,Malaise,6,17201188
3,22.1,Malignant neoplasm progression,6,17201188
4,22.1,Renal impairment,3,17201188
5,22.1,Dyspnoea,6,17201188
6,22.1,Bone marrow failure,1,17201188
0,22.1,Hepatitis acute,6,17201189
0,22.1,Malignant pleural effusion,6,17201193
1,22.1,Interstitial lung disease,6,17201193
0,22.1,Prostatic specific antigen increased,3,17201237
0,22.1,Drug ineffective,6,17201247
0,22.1,Neoplasm progression,6,17201312
1,22.1,Pneumonia,6,17201312
0,22.1,Drug ineffective,6,17201334
0,22.1,Abscess neck,3,17201384
1,22.1,Dysphagia,6,17201384
2,22.1,Lymphadenopathy,6,17201384
0,22.1,Intercepted product preparation error,,17201432
1,22.1,Product leakage,,17201432
2,22.1,Wrong technique in product usage process,,17201432
0,22.1,Pyrexia,2,17201442
1,22.1,Bone marrow failure,1,17201442
0,22.1,Dyspnoea,6,17201446
1,22.1,Escherichia urinary tract infection,6,17201446
2,22.1,Headache,2,17201446
3,22.1,Back pain,1,17201446
4,22.1,Renal impairment,6,17201446
0,22.1,Platelet count decreased,3,17201448
1,22.1,Red blood cell count decreased,6,17201448
2,22.1,Drug ineffective,6,17201448
3,22.1,White blood cell count decreased,6,17201448
4,22.1,Fatigue,1,17201448
5,22.1,Disease progression,6,17201448
6,22.1,Constipation,1,17201448
0,22.1,Diarrhoea,,17201487
0,22.1,Neutropenia,1,17201492
1,22.1,Off label use,6,17201492
0,22.1,Small for dates baby,6,17201496
1,22.1,Foetal exposure during pregnancy,1,17201496
0,22.1,Peripheral swelling,1,17201517
1,22.1,Cardiac failure congestive,4,17201517
2,22.1,Fluid overload,4,17201517
3,22.1,Upper respiratory tract infection,4,17201517
0,22.1,Hypertensive crisis,1,17201560
0,22.1,Infusion related reaction,1,17201563
0,22.1,Intercepted product administration error,6,17201592
1,22.1,Product preparation error,6,17201592
2,22.1,Drug ineffective,6,17201592
3,22.1,Product leakage,6,17201592
4,22.1,Underdose,6,17201592
0,22.1,Peripheral swelling,,17201594
0,22.1,Metastases to liver,,17201599
1,22.1,Tumour marker increased,,17201599
2,22.1,Colorectal cancer,,17201599
0,22.1,Death,,17201602
0,22.1,Transaminases increased,4,17201607
0,22.1,Hepatic failure,,17201629
0,22.1,Death,,17201633
0,22.1,Product leakage,,17201637
1,22.1,Intercepted product preparation error,,17201637
0,22.1,Drug ineffective,6,17201672
0,22.1,Disease progression,,17201720
0,22.1,Vomiting,4,17201721
1,22.1,Nausea,4,17201721
2,22.1,Febrile neutropenia,1,17201721
3,22.1,Pyrexia,1,17201721
4,22.1,Small intestinal obstruction,1,17201721
0,22.1,Diarrhoea,6,17201733
1,22.1,Alopecia,3,17201733
2,22.1,Scab,6,17201733
3,22.1,Skin laceration,6,17201733
4,22.1,Nausea,6,17201733
5,22.1,Pain of skin,3,17201733
6,22.1,Rash,1,17201733
7,22.1,Dermatitis acneiform,6,17201733
8,22.1,Paraesthesia,3,17201733
9,22.1,Pruritus,6,17201733
10,22.1,Alopecia,6,17201733
11,22.1,Acne,6,17201733
12,22.1,Pain of skin,6,17201733
13,22.1,Dry skin,6,17201733
14,22.1,Dermatitis acneiform,3,17201733
15,22.1,Malignant neoplasm progression,6,17201733
0,22.1,Off label use,6,17201763
1,22.1,Cholestasis,4,17201763
2,22.1,Condition aggravated,4,17201763
3,22.1,Hepatocellular injury,1,17201763
0,22.1,Dehydration,5,17201768
1,22.1,Fatigue,3,17201768
2,22.1,Asthenia,3,17201768
3,22.1,Abdominal pain,3,17201768
4,22.1,Haemoglobin decreased,6,17201768
5,22.1,Malnutrition,5,17201768
6,22.1,Gastrooesophageal reflux disease,3,17201768
7,22.1,Hypotension,3,17201768
8,22.1,Anaemia,3,17201768
9,22.1,Decreased appetite,5,17201768
0,22.1,Asthenia,,17201785
1,22.1,Bone marrow failure,5,17201785
2,22.1,Platelet count decreased,3,17201785
3,22.1,Metastases to bone marrow,5,17201785
4,22.1,Haematocrit decreased,3,17201785
0,22.1,Decreased appetite,1,17201800
1,22.1,Performance status decreased,6,17201800
2,22.1,Nausea,1,17201800
0,22.1,Cough,6,17201835
0,22.1,Second primary malignancy,6,17201855
0,22.1,Intentional dose omission,,17201859
1,22.1,Surgery,,17201859
0,22.1,Asthenia,6,17201860
1,22.1,Musculoskeletal pain,6,17201860
2,22.1,Muscular weakness,6,17201860
3,22.1,Fatigue,6,17201860
4,22.1,Smear cervix abnormal,6,17201860
5,22.1,Dyspepsia,6,17201860
6,22.1,Pain in extremity,6,17201860
7,22.1,Headache,6,17201860
8,22.1,Arthralgia,6,17201860
0,22.1,Metastases to bone,6,17201881
1,22.1,Metastases to liver,6,17201881
0,22.1,Nervousness,6,17201903
0,22.1,Premature ageing,6,17201918
1,22.1,Diarrhoea,6,17201918
2,22.1,Feeling abnormal,6,17201918
3,22.1,Pain,6,17201918
4,22.1,Balance disorder,6,17201918
5,22.1,Fatigue,6,17201918
0,22.1,Malaise,6,17201921
0,22.1,Pyrexia,2,17201944
0,22.1,Nasopharyngitis,1,17201950
1,22.1,White blood cell count decreased,1,17201950
0,22.1,Pruritus,3,17201966
1,22.1,Skin exfoliation,6,17201966
2,22.1,White blood cell count decreased,6,17201966
3,22.1,Rash,6,17201966
4,22.1,Sinusitis,1,17201966
0,22.1,Constipation,6,17201967
1,22.1,Dysphonia,6,17201967
2,22.1,Abdominal pain upper,6,17201967
3,22.1,Pharyngeal swelling,6,17201967
4,22.1,Intentional product misuse,6,17201967
5,22.1,Diarrhoea,6,17201967
0,22.1,Death,5,17201997
0,22.1,Off label use,6,17202048
1,22.1,Product quality issue,3,17202048
0,22.1,Accidental underdose,6,17202059
0,22.1,Unevaluable event,6,17202075
0,22.1,Condition aggravated,3,17202076
1,22.1,Dry skin,6,17202076
2,22.1,Insomnia,6,17202076
3,22.1,Anxiety,6,17202076
4,22.1,White blood cell count decreased,3,17202076
5,22.1,Asthenia,3,17202076
6,22.1,Alopecia,3,17202076
7,22.1,Fatigue,3,17202076
8,22.1,Disease progression,6,17202076
9,22.1,Diarrhoea,6,17202076
10,22.1,Nail disorder,6,17202076
11,22.1,Feeling abnormal,6,17202076
12,22.1,Thirst,3,17202076
13,22.1,Pelvic mass,6,17202076
14,22.1,Dehydration,6,17202076
15,22.1,Abdominal pain,3,17202076
16,22.1,Radiation injury,6,17202076
0,22.1,Stevens-Johnson syndrome,1,17202084
0,22.1,Death,5,17202124
1,22.1,Prescribed underdose,6,17202124
2,22.1,Hospitalisation,6,17202124
3,22.1,Diarrhoea,6,17202124
4,22.1,Hospitalisation,6,17202124
5,22.1,Dental operation,6,17202124
0,22.1,Syncope,6,17202139
1,22.1,Nausea,6,17202139
2,22.1,Fatigue,6,17202139
3,22.1,White blood cell count decreased,6,17202139
4,22.1,Hot flush,6,17202139
0,22.1,Urinary tract infection,1,17202145
0,22.1,Depression,6,17202148
1,22.1,Anxiety,6,17202148
0,22.1,Haemoglobin decreased,3,17202155
1,22.1,Blood count abnormal,3,17202155
2,22.1,Red blood cell count decreased,3,17202155
3,22.1,Bone marrow failure,3,17202155
4,22.1,White blood cell count decreased,3,17202155
5,22.1,Feeling abnormal,3,17202155
